These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 22155346)

  • 1. Opposite effects of arsenic trioxide on the Nrf2 pathway in oral squamous cell carcinoma in vitro and in vivo.
    Zhang X; Su Y; Zhang M; Sun Z
    Cancer Lett; 2012 May; 318(1):93-8. PubMed ID: 22155346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxysophocarpine Retards the Growth and Metastasis of Oral Squamous Cell Carcinoma by Targeting the Nrf2/HO-1 Axis.
    Liu R; Peng J; Wang H; Li L; Wen X; Tan Y; Zhang L; Wan H; Chen F; Nie X
    Cell Physiol Biochem; 2018; 49(5):1717-1733. PubMed ID: 30231242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the Nrf2 Signaling Pathway Involving KLF9 Plays a Critical Role in Allicin Resisting Against Arsenic Trioxide-Induced Hepatotoxicity in Rats.
    Yang D; Lv Z; Zhang H; Liu B; Jiang H; Tan X; Lu J; Baiyun R; Zhang Z
    Biol Trace Elem Res; 2017 Mar; 176(1):192-200. PubMed ID: 27561292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arsenic Trioxide Activate Transcription of Heme Oxygenase-1 by Promoting Nuclear Translocation of NFE2L2.
    Yue Z; Zhong L; Mou Y; Wang X; Zhang H; Wang Y; Xia J; Li R; Wang Z
    Int J Med Sci; 2015; 12(8):674-9. PubMed ID: 26283888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined arsenic trioxide-cisplatin treatment enhances apoptosis in oral squamous cell carcinoma cells.
    Nakaoka T; Ota A; Ono T; Karnan S; Konishi H; Furuhashi A; Ohmura Y; Yamada Y; Hosokawa Y; Kazaoka Y
    Cell Oncol (Dordr); 2014 Apr; 37(2):119-29. PubMed ID: 24599717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of nicotinamide phosphoribosyltransferase and depletion of nicotinamide adenine dinucleotide contribute to arsenic trioxide suppression of oral squamous cell carcinoma.
    Wang XY; Wang JZ; Gao L; Zhang FY; Wang Q; Liu KJ; Xiang B
    Toxicol Appl Pharmacol; 2017 Sep; 331():54-61. PubMed ID: 28501332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cepharanthine alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Harada K; Ferdous T; Itashiki Y; Takii M; Mano T; Mori Y; Ueyama Y
    Anticancer Res; 2009 Apr; 29(4):1263-70. PubMed ID: 19414373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of heme oxygenase-1 enhances anti-cancer effects of arsenic trioxide on glioma cells.
    Liu Y; Liang Y; Zheng T; Yang G; Zhang X; Sun Z; Shi C; Zhao S
    J Neurooncol; 2011 Sep; 104(2):449-58. PubMed ID: 21327864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive oxygen species are not required for an arsenic trioxide-induced antioxidant response or apoptosis.
    Morales AA; Gutman D; Cejas PJ; Lee KP; Boise LH
    J Biol Chem; 2009 May; 284(19):12886-95. PubMed ID: 19279006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [miR-155/BACH1 Signaling Pathway in Human Lung Adenocarcinoma Cell Death Induced by Arsenic Trioxide].
    Gu SY; Chen HY; Dai HM; Li XY; Zhang ZZ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Nov; 48(6):828-833. PubMed ID: 29260515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Curcumin attenuates arsenic-induced hepatic injuries and oxidative stress in experimental mice through activation of Nrf2 pathway, promotion of arsenic methylation and urinary excretion.
    Gao S; Duan X; Wang X; Dong D; Liu D; Li X; Sun G; Li B
    Food Chem Toxicol; 2013 Sep; 59():739-47. PubMed ID: 23871787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Mechanisms of arsenic trioxide induced tumor cell apoptosis in myelodysplastic syndrome mice model in vivo].
    Lu J; Jin J
    Zhonghua Er Ke Za Zhi; 2006 Oct; 44(10):782-6. PubMed ID: 17229386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryptotanshinone enhances the effect of Arsenic trioxide in treating liver cancer cell by inducing apoptosis through downregulating phosphorylated- STAT3 in vitro and in vivo.
    Shen L; Zhang G; Lou Z; Xu G; Zhang G
    BMC Complement Altern Med; 2017 Feb; 17(1):106. PubMed ID: 28187727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PM2.5 induces Nrf2-mediated defense mechanisms against oxidative stress by activating PIK3/AKT signaling pathway in human lung alveolar epithelial A549 cells.
    Deng X; Rui W; Zhang F; Ding W
    Cell Biol Toxicol; 2013 Jun; 29(3):143-57. PubMed ID: 23525690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS.
    Kanno T; Tanaka K; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Hirayama N; Ikeda JE
    Free Radic Biol Med; 2012 Dec; 53(11):2028-42. PubMed ID: 23000247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Investigation of apoptosis mechanism of arsenic trioxide on oral squamous cell carcinoma].
    Guo J; Zhang ZY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2003 Jan; 38(1):20-3. PubMed ID: 12760770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near infrared imaging of EGFR of oral squamous cell carcinoma in mice administered arsenic trioxide.
    Zhang L; Wang K; Zhao F; Hu W; Chen J; Lanza GM; Shen B; Zhang B
    PLoS One; 2012; 7(9):e46255. PubMed ID: 23029451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination effects of arsenic trioxide and fibroblast growth factor receptor inhibitor in squamous cell lung carcinoma.
    Lam SK; Leung LL; Li YY; Zheng CY; Ho JC
    Lung Cancer; 2016 Nov; 101():111-119. PubMed ID: 27794399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of RANKL/RANK signaling by osteoprotegerin suppresses bone invasion by oral squamous cell carcinoma cells.
    Shin M; Matsuo K; Tada T; Fukushima H; Furuta H; Ozeki S; Kadowaki T; Yamamoto K; Okamoto M; Jimi E
    Carcinogenesis; 2011 Nov; 32(11):1634-40. PubMed ID: 21890459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo anti-tumor effect of metformin as a novel therapeutic agent in human oral squamous cell carcinoma.
    Luo Q; Hu D; Hu S; Yan M; Sun Z; Chen F
    BMC Cancer; 2012 Nov; 12():517. PubMed ID: 23151022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.